1. Non-circadian aspects of BHLHE40 cellular function in cancer
    Zsofia Kiss et al, 2020, Genes & Cancer CrossRef
  2. Stra13 and Sharp-1, the Non-Grouchy Regulators of Development and Disease
    Jin Rong Ow et al, 2014, bHLH Transcription Factors in Development and Disease CrossRef
  3. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
    Francesco Ciccarese et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  4. Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma
    Melika Hajimohammadebrahim-Ketabforoush et al, 2024, Frontiers in Oncology CrossRef
  5. Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells
    Irem Dogan Turacli et al, 2018, Human & Experimental Toxicology CrossRef
  6. Band Alignment-Driven Oxidative Injury to the Skin by Anatase/Rutile Mixed-Phase Titanium Dioxide Nanoparticles Under Sunlight Exposure
    Xiujuan Sun et al, 2018, Toxicological Sciences CrossRef
  7. Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
    Yuyang Liu et al, 2019, Cancer Cell International CrossRef
  8. Epigenetic Aspects of Hepatocellular Carcinoma Chemoprevention
    Renato Heidor et al, 2019, Epigenetics of Cancer Prevention CrossRef
  9. Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study
    Yu-Tang Chang et al, 2018, Translational Oncology CrossRef
  10. Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
    Samson Samuel et al, 2019, Biomolecules CrossRef
  11. 6-Bromoindirubin-3′-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes Autophagy, and Exerts Anti-aging Effects in Rodent Liver
    Donghao Guo et al, 2019, Frontiers in Pharmacology CrossRef
  12. Antitumor activity of Metformin through p53 and Cyclin D1 in the Urothelial Cell Carcinoma
    Anny Setijo Rahaju et al, 2023, Research Journal of Pharmacy and Technology CrossRef
  13. Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population
    Na-Yon Kim et al, 2021, Oncology Letters CrossRef
  14. 6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation
    Jingzhang Fan et al, 2015, Tumor Biology CrossRef
  15. Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy
    Marianne Koritzinsky, 2015, International Journal of Radiation Oncology*Biology*Physics CrossRef
  16. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase
    Yao-Li Chen et al, 2017, Biochemical Pharmacology CrossRef
  17. The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct


    Liangyuan Long et al, 2020, OncoTargets and Therapy CrossRef
  18. Association of sirtuins (SIRT1-7) with lung and intestinal diseases
    Yuhan Chen et al, 2022, Molecular and Cellular Biochemistry CrossRef
  19. Repurposing Drugs in Small Animal Oncology
    Antonio Giuliano et al, 2022, Animals CrossRef
  20. Repurposing drugs for the treatment of glioma
    Yaodong Zhao et al, 2019, Glioma CrossRef
  21. Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis
    Julia A. Loos et al, 2022, Parasitology CrossRef
  22. Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
    Samson Mathews Samuel et al, 2020, Cancers CrossRef
  23. The Gut Microbiome, Metformin, and Aging
    Sri Nitya Reddy Induri et al, 2022, Annual Review of Pharmacology and Toxicology CrossRef
  24. Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6‐independent manner
    Feng‐Shu Hsieh et al, 2017, Molecular Oncology CrossRef
  25. Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
    Yu Hua et al, 2023, Journal of Translational Medicine CrossRef
  26. Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment
    Xinbing Sui et al, 2015, Molecular Pharmaceutics CrossRef
  27. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
    Marius Farcas et al, 2019, Frontiers in Nutrition CrossRef
  28. The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
    Xue Jiang et al, 2019, Cancers CrossRef
  29. Absence of AMPKα2 accelerates cellular senescence via p16 induction in mouse embryonic fibroblasts
    Ye Ding et al, 2016, The International Journal of Biochemistry & Cell Biology CrossRef
  30. Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts
    Xinke Zhou et al, 2017, Cancer Letters CrossRef
  31. Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions
    Robert Haas et al, 2015, PLOS Biology CrossRef
  32. Metformin Induces PRODH/POX-Dependent Apoptosis in Breast Cancer Cells
    Thi Yen Ly Huynh et al, 2022, Frontiers in Molecular Biosciences CrossRef
  33. Impact of insulin resistance on hepatocellular carcinoma
    Takumi Kawaguchi et al, 2015, Kanzo CrossRef
  34. Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis
    Zhaodi Zheng et al, 2020, Cell Cycle CrossRef
  35. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
    Stephen L. Abrams et al, 2021, Advances in Biological Regulation CrossRef
  36. Phytol and (−)-α-bisabolol Synergistically trigger intrinsic apoptosis through redox and Ca2+ imbalance in non-small cell lung cancer
    Chandramohan Kiruthiga et al, 2024, Biocatalysis and Agricultural Biotechnology CrossRef
  37. Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)
    Nerea Allende-Vega et al, 2022, Scientific Reports CrossRef
  38. A new contribution for an old drug
    Shangze Jiang et al, 2021, Journal of Cancer Research and Therapeutics CrossRef
  39. Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts
    Yuya Sugimoto et al, 2024, Oncology Reports CrossRef
  40. Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis
    Michael E. Grossmann et al, 2015, Current Pharmacology Reports CrossRef
  41. Targeting AMPK for cancer prevention and treatment
    Weidong Li et al, 2015, Oncotarget CrossRef
  42. The Potential Effect of Metformin on Cancer: An Umbrella Review
    Hong Yu et al, 2019, Frontiers in Endocrinology CrossRef
  43. Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer
    Yan Bian et al, 2020, International Journal of Molecular Sciences CrossRef
  44. 4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling
    Yen-Lin Chen et al, 2020, The American Journal of Chinese Medicine CrossRef
  45. Radiation-induced senescence: therapeutic opportunities
    Jae Ho Kim et al, 2023, Radiation Oncology CrossRef
  46. Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
    Maja Cigrovski Berkovic et al, 2023, World Journal of Diabetes CrossRef
  47. Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression
    Xiaowan Chen et al, 2016, Cancer Biology & Therapy CrossRef
  48. p53 and metabolism: from mechanism to therapeutics
    Fernando M. Simabuco et al, 2018, Oncotarget CrossRef
  49. Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway
    Yuanyuan Liu et al, 2020, Life Sciences CrossRef
  50. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma
    Su Youn Baek et al, 2020, Biomolecules CrossRef
  51. Mechanisms of cancer cell killing by metformin: a review on different cell death pathways
    Xiao-yu Wu et al, 2023, Molecular and Cellular Biochemistry CrossRef
  52. Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts
    Nur-Afidah Mohamed Suhaimi et al, 2017, Molecular Cancer Therapeutics CrossRef
  53. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
    Xinke Zhou et al, 2016, Oncotarget CrossRef
  54. Prognostic significance of AMPK in human malignancies: A meta-analysis
    Ji Cheng et al, 2016, Oncotarget CrossRef
  55. Senolytics and senostatics as adjuvant tumour therapy
    Susan Short et al, 2019, EBioMedicine CrossRef
  56. Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib
    Xiaofei Wang et al, 2017, Oncotarget CrossRef
  57. Acidosis‐induced activation of distal nephron principal cells triggers Gdf15 secretion and adaptive proliferation of intercalated cells
    Lydie Cheval et al, 2021, Acta Physiologica CrossRef
  58. Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)
    Izabela Szymczak-Pajor et al, 2023, Pharmaceuticals CrossRef
  59. Biochemical and transcriptomic evaluation of a 3D lung organoid platform for pre-clinical testing of active substances targeting senescence
    Michelle Brand et al, 2024, Respiratory Research CrossRef
  60. Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
    Xilan Yu et al, 2017, Oncotarget CrossRef
  61. SIRT1 and microRNAs: The role in breast, lung and prostate cancers
    Hedyieh Karbasforooshan et al, 2018, Experimental Cell Research CrossRef
  62. Benefits of Metformin in Attenuating the Hallmarks of Aging
    Ameya S. Kulkarni et al, 2020, Cell Metabolism CrossRef
  63. Integrated Stress Response (ISR) Pathway: Unraveling Its Role in Cellular Senescence
    Alexander Kalinin et al, 2023, International Journal of Molecular Sciences CrossRef
  64. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
    Mamatha Bhat et al, 2017, Oncotarget CrossRef
  65. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights
    Ntsoaki Annah Nyane et al, 2017, European Journal of Pharmacology CrossRef
  66. Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53
    Aneta Rogalska et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
  67. Metabolism and immunity in breast cancer
    Deyu Zhang et al, 2021, Frontiers of Medicine CrossRef
  68. Pleiotropic Effects of Metformin in Osteoarthritis
    Sevdalina Nikolova Lambova, 2023, Life CrossRef
  69. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia
    Hsin-Hung Chen et al, 2015, Medicine CrossRef